Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands.
about
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs diseaseThe attitudes and intention to participate in hemoglobinopathy carrier screening in The Netherlands among individuals from Turkish, Moroccan, and Surinamese descentWhole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers.Feasibility of preconception screening for thalassaemia in Indonesia: exploring the opinion of Javanese mothers.Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry.Preconceptional ancestry-based carrier couple screening for cystic fibrosis and haemoglobinopathies: what determines the intention to participate or not and actual participation?Challenges in the care for consanguineous couples: an exploratory interview study among general practitioners and midwives.Screening and genetic diagnosis of hemoglobinopathies in southern and northern europe: two examplesCommentary: a sociologist's view on community genetics.A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the futurePreconception care and genetic risk: ethical issuesPsychosocial aspects of preconception consultation in primary care: lessons from our experience in clinical geneticsNon-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users' perspective.Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy-carrier screeningResponsible implementation of expanded carrier screening.Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.Consanguineous marriage and reproductive risk: attitudes and understanding of ethnic groups practising consanguinity in Western society.Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing?Expanded carrier screening for monogenic disorders: where are we now?Systematic design and comparison of expanded carrier screening panels.Psychosocial Responses to being Identified as a Balanced Chromosomal Translocation Carrier: a Qualitative Investigation of Parents in Japan.Reproductive empowerment: the main motivator and outcome of carrier testing.Experiences of a High-Risk Population with Prenatal Hemoglobinopathy Carrier Screening in a Primary Care Setting: a Qualitative Study.Advantages of expanded universal carrier screening: what is at stake?Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population.Patient actions and reactions after receiving negative results from expanded carrier screening.A prospective, longitudinal study of the impact of GJB2/GJB6 genetic testing on the beliefs and attitudes of parents of deaf and hard-of-hearing infants.
P2860
Q24187920-52D3E235-0102-43AE-933D-65EC26C57369Q29353725-1A08AF8C-A5E4-42FE-81FB-ABF88543A67FQ30391597-6CF0843F-CFF2-479A-BAAA-296D2456AEC0Q33503413-7BF59333-394E-41FF-95C2-C8E0204673DFQ33974057-E35BC8CE-1BA5-4118-93D1-9B30012EA6E7Q34131978-DAD1A389-944B-4B36-920F-2A257BD993AFQ34326885-C37D4249-3EFB-4231-8104-D7D96A6F7439Q34458626-422B9EEF-1025-4B84-B8A3-C8B8EFC08ED5Q34549384-28199FFB-E4F7-4EDE-8252-35BE1DC2A7B2Q35263436-BA2A68F4-D661-4929-9BAF-D720283F574DQ36093912-06B471F5-EF6B-49B7-A042-9F2C49B63DE0Q36164685-0D05D101-DE3D-4D66-BFE3-5D86071AA37FQ36164710-42AA2163-459D-4EB7-B236-6B5AE7AC20FAQ36333978-B83DC6E9-1B90-4E74-975F-CDB22B5A48A5Q36333982-6B91431C-4B42-4CAE-81CC-B24AB397DD8CQ36902740-D4E12FB6-4FAA-43EF-9F39-2BF839F5E2C6Q37471817-92625EDE-1C23-42E7-8012-743D61F76524Q37636712-CB3CF3BD-6FDC-4D47-92E0-9CAFD5C9A5F3Q37794052-F337FC51-9AAD-4615-BC04-23594E340B1DQ39420103-37604658-0FE3-41E3-8618-4ECC8E7733CFQ46843828-7C1DA59C-1E6C-4B0B-A0FB-41DCBECFD164Q47729792-04830D18-03FD-45E7-B5BF-6E89E1891FDEQ48111100-78688092-75B5-4297-970A-851C17D4150AQ48241933-96B48F9D-C22D-442F-BF57-818FC048AE35Q49770816-9BDA21D4-B292-4CA0-ADB4-995B73F34829Q50100807-BE93CC75-47D6-4B2B-8BB3-AE8799197938Q53477865-C2DADF1D-724F-47D4-B335-2F732D307FDBQ55526815-4E9B1031-5D7C-4A07-9393-AE28B8B80DD7
P2860
Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Three-month follow-up of Weste ...... inopathies in the Netherlands.
@en
Three-month follow-up of Weste ...... inopathies in the Netherlands.
@nl
type
label
Three-month follow-up of Weste ...... inopathies in the Netherlands.
@en
Three-month follow-up of Weste ...... inopathies in the Netherlands.
@nl
prefLabel
Three-month follow-up of Weste ...... inopathies in the Netherlands.
@en
Three-month follow-up of Weste ...... inopathies in the Netherlands.
@nl
P2093
P2860
P1433
P1476
Three-month follow-up of Weste ...... inopathies in the Netherlands.
@en
P2093
Leo P ten Kate
Lidewij Henneman
Phillis Lakeman
Pieter D Bezemer
P2860
P2888
P304
P356
10.1097/GIM.0B013E318188D04C
P407
P577
2008-11-01T00:00:00Z
P6179
1037654858